>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>(±)-Clorprenaline-d7

(±)-Clorprenaline-d7 (Synonyms: Isoprophenamine-d7)

Catalog No.GC46283

A neuropeptide with diverse biological activities

Products are for research use only. Not for human use. We do not sell to patients.

(±)-Clorprenaline-d7 Chemical Structure

Cas No.: 2748354-86-9

Size 가격 재고 수량
1 mg
US$272.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(±)-Clorprenaline-d7 is intended for use as an internal standard for the quantification of clorprenaline by GC- or LC-MS. Clorprenaline is a β2-adrenergic receptor agonist.1 It reverses pilocarpine-induced constriction of isolated guinea pig trachea, rabbit lung, and bronchi of pithed dogs.2 It has been detected in pork, beef, mutton, and chicken muscle food samples by UPLC-Q-orbitrap-HRMS.1 Formulations containing clorprenaline have been used as partitioning agents and growth promoters in livestock.

1.Guo, C., Shi, F., Gong, L., et al.Ultra-trace analysis of 12 β2-agonists in pork, beef, mutton and chicken by ultrahigh-performance liquid-chromatography-quadrupole-orbitrap tandem mass spectrometryJ. Pharm. Biomed. Anal.107526-534(2015) 2.Powell, C.E., Gibson, W.R., and Swanson, E.E.The pharmacological action of 1-o-chlorophenyl-2-isopropylaminoethanol (isoprophenamine); A bronchodilatorJ. Am. Pharm. Assoc.45(12)785-787(1956)

리뷰

Review for (±)-Clorprenaline-d7

Average Rating: 5 ★★★★★ (Based on Reviews and 35 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (±)-Clorprenaline-d7

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.